<DOC>
	<DOCNO>NCT02227173</DOCNO>
	<brief_summary>This open-label , single-sequence , drug-drug interaction study healthy male female subject . There formal research hypothesis statistically test . It expect coadministration BMS-986020 montelukast , flurbiprofen , digoxin may increase exposure montelukast , flurbiprofen , digoxin .</brief_summary>
	<brief_title>A Phase 1 Drug-drug Interaction Study Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Digoxin</mesh_term>
	<mesh_term>Flurbiprofen</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Healthy male female nonsmoking subject age 18 50 year , inclusive , body mass index 18.0 32.0 kg/m2 , inclusive Women childbearing potential must agree follow instruction method contraception duration study Any significant acute chronic medical illness History arrhythmias palpitation associate dizziness faint History clinically relevant cardiac disease Other protocol define exclusion criterion could apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>